Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter Bothma

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Case Reports|June 8, 2026
Preventing Cerebral Air Embolism Following Central Venous Catheter Removal: The Role of Tissue AdhesivesAnanda Shakya, Pieter Bothma
European Journal of Case Reports in Internal Medicine|March 27, 2023
ISCHAEMIC STROKE, PREVENTABLE WITH TISSUE ADHESIVEPieter Bothma, Goncalo Campos, Ananda Shakya
Emerging Infectious Diseases|December 17, 2016
Analysis of Anthrax Immune Globulin Intravenous with Antimicrobial Treatment in Injection Drug Users, Scotland, 2009-2010Xizhong Cui, Leisha D Nolen, Junfeng Sun, et al.
The Lancet. Oncology|December 26, 2015
Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trialMark Glover, Gary R Smerdon, H Jervoise Andreyev, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Case Reports|June 8, 2026
Preventing Cerebral Air Embolism Following Central Venous Catheter Removal: The Role of Tissue AdhesivesAnanda Shakya, Pieter Bothma
European Journal of Case Reports in Internal Medicine|March 27, 2023
ISCHAEMIC STROKE, PREVENTABLE WITH TISSUE ADHESIVEPieter Bothma, Goncalo Campos, Ananda Shakya
Emerging Infectious Diseases|December 17, 2016
Analysis of Anthrax Immune Globulin Intravenous with Antimicrobial Treatment in Injection Drug Users, Scotland, 2009-2010Xizhong Cui, Leisha D Nolen, Junfeng Sun, et al.
The Lancet. Oncology|December 26, 2015
Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trialMark Glover, Gary R Smerdon, H Jervoise Andreyev, et al.
Pageof 1